NSB 2.70% 3.8¢ neuroscientific biopharmaceuticals ltd

Ann: Change of Director's Interest Notice - Uvarov, page-5

  1. 853 Posts.
    lightbulb Created with Sketch. 5
    Both Chairman/Acting CEO and former Executive Director (now NED) buying within days of each other...
    Pretty strong signal to me. Definitely something is up.

    They must be close to resolving their issues with initiating the Phase 1 study. This is a very promising drug. Shame they had some (probably somewhat self-induced) hiccups along the way.

    Once there's an indication Phase 1 can be initiated, this will rocket back to 20c+ in a blink!

    A.
 
watchlist Created with Sketch. Add NSB (ASX) to my watchlist
(20min delay)
Last
3.8¢
Change
0.001(2.70%)
Mkt cap ! $5.494M
Open High Low Value Volume
3.8¢ 3.8¢ 3.8¢ $4.303K 113.2K

Buyers (Bids)

No. Vol. Price($)
1 50000 3.6¢
 

Sellers (Offers)

Price($) Vol. No.
3.8¢ 35801 1
View Market Depth
Last trade - 11.06am 18/09/2024 (20 minute delay) ?
NSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.